• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Off-Label Use of Direct Oral Anticoagulants in Intracerebral Hemorrhage Patients With Prosthetic Valves.

作者信息

Chaturvedi Seemant, Molina Carlos A, Selim Magdy H, Diener Hans-Christoph, Hohnloser Stefan H

机构信息

From the Department of Neurology and Stroke Program, University of Miami Miller School of Medicine, FL (S.C.); Vall d´Hebron Stroke Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain (C.A.M.); Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA (M.H.S.); Department of Neurology, University Hospital Essen, University Duisburg-Essen, Germany (H.-C.D.); and Division Clinical Electrophysiology, Department of Cardiology, J. W. Goethe University, Frankfurt, Germany (S.H.H.).

出版信息

Stroke. 2017 Nov;48(11):3183-3186. doi: 10.1161/STROKEAHA.117.017592. Epub 2017 Oct 13.

DOI:10.1161/STROKEAHA.117.017592
PMID:29030474
Abstract
摘要

相似文献

1
Off-Label Use of Direct Oral Anticoagulants in Intracerebral Hemorrhage Patients With Prosthetic Valves.直接口服抗凝剂在人工瓣膜脑出血患者中的超说明书用药
Stroke. 2017 Nov;48(11):3183-3186. doi: 10.1161/STROKEAHA.117.017592. Epub 2017 Oct 13.
2
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.非瓣膜性心房颤动且既往有卒中和短暂性脑缺血发作患者中应用阿哌沙班、达比加群和利伐沙班与华法林的有效性和安全性。
Stroke. 2017 Aug;48(8):2142-2149. doi: 10.1161/STROKEAHA.117.017474. Epub 2017 Jun 27.
3
Embolic Stroke, Atrial Fibrillation, and Microbleeds: Is There a Role for Anticoagulation?栓塞性中风、心房颤动与微出血：抗凝治疗有作用吗？
Stroke. 2016 Mar;47(3):904-7. doi: 10.1161/STROKEAHA.115.011150.
4
Protocol for Cerebral Microbleeds during the Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin Therapy in Stroke Patients with Nonvalvular Atrial Fibrillation (CMB-NOW) Study: Multisite Pilot Trial.非维生素K拮抗剂口服抗凝剂或华法林治疗非瓣膜性心房颤动中风患者脑微出血的研究方案（CMB-NOW）：多中心试点试验
J Stroke Cerebrovasc Dis. 2015 Sep;24(9):2143-8. doi: 10.1016/j.jstrokecerebrovasdis.2015.05.032. Epub 2015 Jul 4.
5
[Measurement of Prothrombin Fragment 1+2 for the Assessment of Anticoagulant Activity in Patients Treated with Warfarin or Non-vitamin K Antagonist Oral Anticoagulant].[通过测量凝血酶原片段1+2评估接受华法林或非维生素K拮抗剂口服抗凝剂治疗患者的抗凝活性]
Brain Nerve. 2017 May;69(5):571-576. doi: 10.11477/mf.1416200784.
6
Comparing Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation, Venous Thromboembolism, and Mechanical Heart Valves.比较直接口服抗凝剂与华法林用于心房颤动、静脉血栓栓塞和机械心脏瓣膜的情况。
Consult Pharm. 2015 Nov;30(11):644-56. doi: 10.4140/TCP.n.2015.644.
7
Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.比较达比加群酯与华法林在心房颤动中两剂的获益与风险。
J Am Coll Cardiol. 2013 Sep 3;62(10):900-8. doi: 10.1016/j.jacc.2013.05.042. Epub 2013 Jun 13.
8
Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion.达比加群相关颅内出血导致血肿扩大。
J Stroke Cerebrovasc Dis. 2014 Feb;23(2):e133-4. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.011. Epub 2013 Oct 6.
9
Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.心房颤动卒中后抗凝治疗的三个月风险效益概况：SAMURAI-非瓣膜性心房颤动（NVAF）研究
Int J Stroke. 2016 Jul;11(5):565-74. doi: 10.1177/1747493016632239. Epub 2016 Feb 29.
10
Choice of oral anticoagulants in older patients with non-valvular atrial fibrillation.
Br J Hosp Med (Lond). 2017 Jul 2;78(7):416. doi: 10.12968/hmed.2017.78.7.416.